Abstract
Intracellular calcium has been reported to be increased in essential hypertension, and thought to play a role in its genesis through facilitation of vascular smooth muscle contraction. Since hypertension is more prevalent in primary hyperparathyroidism, intracellular calcium may also be increased in this condition. To investigate whether the hyperparathyroid condition, i.e., hypercalcemia and increased PTH per se, could be associated with high intracellular calcium, we measured intracellular calcium in platelets with the Quin-2 AM fluorometric method in 11 normotensive patients with primary hyperparathyroidism, 15 patients with essential hypertension, and 18 normal controls, all matched for age and sex. We repeated the measurements in 9 of the hyperparathyroid patients after successful surgery. We found that intracellular calcium was higher in normotensive patients with primary hyperparathyroidism than in normal controls (198±24 vs 113±11 nM, p<0.05), but lower than in patients with essential hypertension (198±24 vs 286±38 nM, p<0.05). Successful removal of a parathyroid adenoma decreased intracellular calcium from 215±22 to 116±19 nM, (p<0.01 ). In the patients with primary hyperparathyroidism, intracellular calcium was strongly correlated with the levels of PTH (r=0.87, p<0.01), but not with the total serum calcium levels (r=0.04, NS). The decrease in intracellular calcium after parathyroidectomy was also strongly correlated with the decrease in PTH (r=0.84, p<0.01), but not with the decrease in total serum calcium (r=0.16, NS). In the patients with essential hypertension, intracellular calcium correlated well with systolic (r=0.69, p<0.01), diastolic (r=0.76, p<0.01) and especially mean arterial pressure (r=0.86, p<0.01). There was no correlation between blood pressure and intracellular calcium in the patients with primary hyperparathyroidism. We conclude that normotensive patients with primary hyperparathyroidism, as well as patients with essential hypertension, can have increased concentrations of intracellular calcium in platelets. The correction of the hyperparathyroid condition normalizes intracellular calcium concentration. The close correlation between PTH and intracellular calcium suggests that PTH may act as a ionophore for calcium entry into cells. Whether the increased levels of intracellular calcium may reflect a pre-hypertensive condition in normotensive patients with primary hyperparathyroidism remains to be determined.
Similar content being viewed by others
References
Lafferty F. Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension and discriminant analysis of laboratory tests. Arch. Intern. Med. 141: 1761, 1986.
Rosenthal F.D., Roy S. Hypertension and hyperparathyroidism. Br. Med. J. 4: 396, 1972.
Diamond T., Botha J., Wing J., Meyers A., Kalk J. Parathyroid hypertension. A reversible disorder. Arch. Intern. Med. 146: 17091, 1986.
Johanson B. Vascular smooth muscle reactivity. Ann. Rev. Physiol. 43: 359, 1981.
Murphy R.A. Myosin phosphorylation and cross-bridge regulation in arterial smooth muscle: state-of-the-art review. Hypertension 4(Suppl II): II–3, 1982.
Rasmussen H. The calcium messenger system (First of two parts). N. Engl. J. Med. 314: 1094, 1986.
Rasmussen H. The calcium messenger system (Second of two parts). N. Engl. J. Med. 314: 1164, 1986.
Lau K., Eby B. The role of calcium in genetic hypertension. Hypertension 7: 657, 1985.
Schleiffer R., Berthelot A., Gairard A. Action of parathyroid extract on arterial blood pressure and on contraction and 45Ca exchange in isolated aorta in the rat. Eur. J. Pharmacol. 58: 163, 1979.
Erne P., Bolli P., Burgisser E., Buhler F. Correlation of platelet calcium with blood pressure: effect of antihypertensive therapy. N. Engl. J. Med. 310: 1084, 1984.
Erne P., Burgisser E., Bolli P., Baohva J., Buhler F.R. Free calcium concentration in platelets closely relates to blood pressure in normal and essential hypertensive subjects. Hypertens. 6(Suppl 1): I–166, 1984.
Zidek W., Spieker C., Vetter H. Cai 2 Ki, ratio and total intracellular calcium in essential and renal hypertension. J. Hypertension 4: 507, 1986.
Zidek W., Vetter H., Dorst K.-G., Zumkley H., Loose H. Intracellular Na+ and Ca+2 activities in essential hypertension. Clin. Sci. 63: 41s, 1982.
Postnov Y., Orlov S., Pokudin N. Alteration of intracellular calcium distribution in the adipocyte tissue of human patients with essential hypertension. Pflügers Arch. 388: 89, 1980.
Erne P., Buhler F.R., Affolter H., Burgisser E. Excitatory and inhibitory modulation of intracellular free calcium in human platelets by hormones and drugs. Eur. J. Pharmacol. 91: 331, 1983.
Hinssen H., D’Haese J., Samll J.V., Solieszek A. Mode of filament assembly of myosins from muscle and non muscle cells. J. Ultrastruct. Des. 64: 282, 1978.
Niederman R., Pollard T.D. Human platelet myosin II. In vitro assembly and structure of myosin filaments. J. Cell. Biol. 67: 72, 1975.
Tsien R., Pozzani T., Rink T. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellulary-trapped fluorescent indicator. J. Cell. Biol. 94: 325, 1982.
Campino C., Bruggendieck B., Pumarino H., Rojas A., Ferreiro F. Desarrollo de un radioinmunoanalisis (RIA) para fracción media de hormona paratiroidea (M-PTH). Comparacion con 2 kits comerciales para carboxilo terminal. Rev. Med. Chile 115: 7631, 1987.
Raine A., Bedford L., Simpson A., Ashley C., Brown R., Woohead J., Ledingham J. Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure. Kidney Int. 43: 700, 1993.
Hruska K.A., Moskowitz D., Esbrit P., Civitelli R., Westbrook S., Huskey M. Stimulation of inositol triphosphate and diacylglicerol production in renal tubular cells by parathyroid hormone. J. Clin. Invest. 79: 230, 1987.
Kawashima H. Parathyroid hormone causes a transient rise in intra-cellular ionized calcium in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 166: 709, 1990.
Remuzzi G., Benigni A., Dodesini P., Schieppati A., Livio M., Poletti E., Mecca G., Gaetano G. Parathyroid hormone inhibits human platelet function. Lancet ii: 1321, 1981.
Hutler H.N., Melby J.C., Peterson J.C., Cooke C.R. Chronic continuous PTH infusion results in hypertension in normal subjects. J. Clin. Hypertens. 4: 360, 1989.
Kishimoto H., Tsumura K., Fujioka S., Uchimoto S., Morii H. Chronic parathyroid hormone administration reverses the antihypertensive effect of calcium loading in young spontaneously hypertensive rats. Am. J. Hypertens. 6: 234, 1993.
Mok L., Nickols A., Thompson J., Cooper C. Parathyroid hormone as a smooth muscle relaxant. Endocr. Rev. 10: 420, 1989.
Vlachakis N.D., Frederics R., Velasquez M., Alexander N., Singer F., Maronde R.F. Sympathetic system function and vascular reactivity in hypercalcemic patients. Hypertension 4: 452, 1982.
Rodriguez-Portales J.A., Fardella C. Primary hyperparathyroidism and hypertension: Persistently abnormal pressor sensitivity in normotensive patients after surgical cure. J. Endocrinol. Invest. 17: 307, 1994.
Oshima T., Young E.W., McCarron D.A. Abnormal platelet and lymphocyte calcium handling in prehypertensive rats. Hypertension 18: 111, 1991.
Morris C., Vincenzi F., McCarron D. Ca2+ ATPase activity in human hypertension. Kidney Int. 27: 197, 1985 (Abstr.).
Devynck M.-A., Pernollet M.-G., Nuhez A.-M., Meyer P. Analysis of calcium handling in erythrocytes of genetically hypertensive rats. Hypertension 3: 397, 1981.
Robinson B.F., Dobbs R.J., Kelsey C.R. Effects of nifedipine on resistance vessels, arteries and veins in man. Br. J. Clin. Pharmacol. 10: 433, 1980.
Hulthen U.L., Bolli P., Amann F.W., Kiowski W., Buhler F.R. Enhanced vasodilatation in essential hypertension by calcium channel blockade with verapamil. Hypertension 4(Suppl 2): II–26, 1982.
Author information
Authors and Affiliations
Additional information
This work was supported in part by Grant#246/88 from FONDECYT (Chile).
Rights and permissions
About this article
Cite this article
Fardella, C., Rodriguez-Portales, J.A. Intracellular calcium and blood pressure: Comparison between primary hyperparathyroidism and essential hypertension. J Endocrinol Invest 18, 827–832 (1995). https://doi.org/10.1007/BF03349828
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349828